Hdv Chempharm (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.64 M
- Company Age 25 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 530.27%
- Profit Growth 132.71%
- Ebitda 153.65%
- Net Worth 8.63%
- Total Assets -5.45%
About Hdv Chempharm (India)
Hdv Chempharm (India) Private Limited (HCIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 April 1999 and has a history of 25 years and nine months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.64 M, as per Ministry of Corporate Affairs (MCA) records.
Hasmukhlal Dhirajlal, Harish Dhirajlal, and Jyotsna Vora serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1999PTC042277
-
Company No.
042277
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Apr 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Hdv Chempharm (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hasmukhlal Dhirajlal
|
Director | 15-Apr-1999 | Current |
|
Harish Dhirajlal
|
Director | 15-Apr-1999 | Current |
|
Jyotsna Vora
|
Director | 15-May-1999 | Current |
Financial Performance of Hdv Chempharm (India).
Hdv Chempharm (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 530.27% increase. The company also saw a substantial improvement in profitability, with a 132.71% increase in profit. The company's net worth moved up by a moderate rise of 8.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hdv Chempharm (India)?
In 2023, Hdv Chempharm (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Panvo Organics Private LimitedHasmukhlal Dhirajlal is a mutual person
-
Av Edible Ingredients Private LimitedHasmukhlal Dhirajlal is a mutual person
-
Kito Meditech Private Limited
Hasmukhlal Dhirajlal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hdv Chempharm (India)?
Unlock and access historical data on people associated with Hdv Chempharm (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hdv Chempharm (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hdv Chempharm (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.